<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/" version="2.0">
<channel>
<title>
<![CDATA[ Fierce Pharma ]]>
</title>
<description>
<![CDATA[ Fierce Pharma delivers breaking news and analysis about drug companies, the FDA and the broader pharma industry, including manufacturing, marketing and finance. ]]>
</description>
<link>https://www.fiercepharma.com/</link>
<image>
<url>https://qtxasset.com/quartz/qcloud5/fiercefavicon.ico</url>
<title>Fierce Pharma</title>
<link>https://www.fiercepharma.com/</link>
</image>
<generator>https://rss.app</generator>
<lastBuildDate>Wed, 18 Jun 2025 09:48:27 GMT</lastBuildDate>
<atom:link href="https://rss.app/feeds/TICvGA7W7zZIYi5d.xml" rel="self" type="application/rss+xml"/>
<language>
<![CDATA[ en ]]>
</language>
<item>
<title>
<![CDATA[ Lawmakers refresh tax-dodging accusations against Big Pharma, targeting Pfizer, AbbVie and others ]]>
</title>
<description>
<![CDATA[ <div><img src="https://qtxasset.com/quartz/qcloud5/media/image/Featured%20Images%20-%20Fierce%20Healthcare%20-%202025-05-21T151739.628.jpg?VersionId=QDlsQci3q6SiykgE9YNO0weKf3Y_yrMZ" style="width: 100%;" /><div>Two Democratic lawmakers have renewed accusations that large pharma companies have evaded paying U.S. taxes through a legislative loophole that drugmakers are allegedly lobbying to retain. | Two Democratic lawmakers have renewed accusations that large pharma companies have evaded paying U.S. taxes through a legislative loophole that drugmakers are allegedly lobbying to retain.</div></div> ]]>
</description>
<link>https://www.fiercepharma.com/pharma/lawmakers-refresh-tax-dodging-accusations-against-pharma-targeting-pfizer-abbvie-and-others</link>
<guid isPermaLink="false">069b54a8729b8bd4a887a8a60a03f33b</guid>
<dc:creator>
<![CDATA[ Angus Liu ]]>
</dc:creator>
<pubDate>Tue, 17 Jun 2025 20:56:05 GMT</pubDate>
<media:content medium="image" url="https://qtxasset.com/quartz/qcloud5/media/image/Featured%20Images%20-%20Fierce%20Healthcare%20-%202025-05-21T151739.628.jpg?VersionId=QDlsQci3q6SiykgE9YNO0weKf3Y_yrMZ"/>
</item>
<item>
<title>
<![CDATA[ Ousted ACIP members fire back at RFK Jr.'s 'destabilizing' decisions for US vaccine policy ]]>
</title>
<description>
<![CDATA[ <div><img src="https://qtxasset.com/quartz/qcloud5/media/image/Featured%20Images%20-%20Fierce%20Healthcare%20-%202025-03-26T100147.764.jpg?VersionId=j5c.NUVs.Ff0j7PJp2nDpX3EdDSnsPUh" style="width: 100%;" /><div>Following HHS secretary Robert F. | Following HHS secretary Robert F. Kennedy Jr.’s decision last week to purge the CDC’s Advisory Committee on Immunization Practices and appoint his own replacements, the 17 ousted experts are hitting back at the arguments behind the cull.</div></div> ]]>
</description>
<link>https://www.fiercepharma.com/pharma/ousted-acip-members-fire-back-rfk-jrs-destabilizing-decisions-us-vaccine-policy</link>
<guid isPermaLink="false">9b3b85b37af8e39435acb75ad56bbb73</guid>
<dc:creator>
<![CDATA[ Fraiser Kansteiner ]]>
</dc:creator>
<pubDate>Tue, 17 Jun 2025 18:32:17 GMT</pubDate>
<media:content medium="image" url="https://qtxasset.com/quartz/qcloud5/media/image/Featured%20Images%20-%20Fierce%20Healthcare%20-%202025-03-26T100147.764.jpg?VersionId=j5c.NUVs.Ff0j7PJp2nDpX3EdDSnsPUh"/>
</item>
<item>
<title>
<![CDATA[ IPG Health outfits dominate another Cannes agency showdown, with Real Chemistry and Ogilvy Health earning accolades, too ]]>
</title>
<description>
<![CDATA[ <div><img src="https://qtxasset.com/quartz/qcloud5/media/image/canneslionstrophy.jpg?VersionId=GcioSKRGd.L8G1FX5NmKrb0QWbOVoCEW" style="width: 100%;" /><div>Each year in mid-June, advertising agencies that work behind the scenes to execute drug ads are rewarded with their moment in the spotlight as the biggest award event in advertising plays out in Ca | Cannes Lions named FCB Health the Healthcare Network of the Year, while AREA 23 is the Healthcare Agency of the year. Both agencies are arms of IPG Health.</div></div> ]]>
</description>
<link>https://www.fiercepharma.com/marketing/ipg-health-agencies-dominate-another-cannes-agency-award-showdown-real-chemistry-and</link>
<guid isPermaLink="false">f886dc6a02234e27bfb3b35e466cbf96</guid>
<dc:creator>
<![CDATA[ Zoey Becker ]]>
</dc:creator>
<pubDate>Tue, 17 Jun 2025 18:28:17 GMT</pubDate>
<media:content medium="image" url="https://qtxasset.com/quartz/qcloud5/media/image/canneslionstrophy.jpg?VersionId=GcioSKRGd.L8G1FX5NmKrb0QWbOVoCEW"/>
</item>
<item>
<title>
<![CDATA[ In setback for biopharma, Senate version of Trump's tax bill drops Orphan Cures Act ]]>
</title>
<description>
<![CDATA[ <div><img src="https://qtxasset.com/quartz/qcloud5/media/image/Capitol.jpg?VersionId=AFhgRf63sszBpsQ7IlkNCNDTxTtSJim0" style="width: 100%;" /><div>The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend an Inflation Reduction Act (IRA) provision currently affecting treatment | The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend an Inflation Reduction Act provision currently affecting treatments for rare diseases.</div></div> ]]>
</description>
<link>https://www.fiercepharma.com/pharma/orphan-drug-fix-ira-dropped-senate-version-big-beautiful-bill-setback-biopharma</link>
<guid isPermaLink="false">29bc7362ab857b2f858c7b8b9761a809</guid>
<dc:creator>
<![CDATA[ Angus Liu ]]>
</dc:creator>
<pubDate>Tue, 17 Jun 2025 15:30:21 GMT</pubDate>
<media:content medium="image" url="https://qtxasset.com/quartz/qcloud5/media/image/Capitol.jpg?VersionId=AFhgRf63sszBpsQ7IlkNCNDTxTtSJim0"/>
</item>
<item>
<title>
<![CDATA[ Trump rekindles pharmaceutical tariff threat, suggesting import duties could come 'very soon': Reuters ]]>
</title>
<description>
<![CDATA[ <div><img src="https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-2197351521.jpg?VersionId=lviRiiy6I0bXXgebONwk_cgOUD4yGwVE" style="width: 100%;" /><div>With the industry in a holding pattern, President Donald Trump is again beating the drum for pharmaceutical import tariffs—though the exact nature and timing of their implementation remains unclear | With the industry in a holding pattern, President Donald Trump is again beating the drum for pharmaceutical import tariffs—though the exact nature and timing of their implementation remains unclear as ever.</div></div> ]]>
</description>
<link>https://www.fiercepharma.com/manufacturing/pharma-stocks-slide-trump-renews-tariff-threats-reuters</link>
<guid isPermaLink="false">fc346e490277dfcfb1ea67ff33247d0a</guid>
<dc:creator>
<![CDATA[ Fraiser Kansteiner ]]>
</dc:creator>
<pubDate>Tue, 17 Jun 2025 15:21:00 GMT</pubDate>
<media:content medium="image" url="https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-2197351521.jpg?VersionId=lviRiiy6I0bXXgebONwk_cgOUD4yGwVE"/>
</item>
<item>
<title>
<![CDATA[ With FDA nod for HAE drug Andembry, CSL set to compete with Takeda's Takhzyro ]]>
</title>
<description>
<![CDATA[ <div><img src="https://qtxasset.com/quartz/qcloud5/media/image/ANDEMBRY3.jpg?VersionId=gWgco.U5tuhO301XyrDe2IVYCkzdy8Wh" style="width: 100%;" /><div>After gaining approvals in Japan, Europe and the U.K. | With the FDA's approval of hereditary angioedema preventative treatment Andembry, CSL is ready to take on Takeda’s blockbuster Takhzyro and BioCryst Pharmaceuticals’ fast-rising Orladeyo in a competitive market to treat patients with the rare genetic condition.</div></div> ]]>
</description>
<link>https://www.fiercepharma.com/pharma/fda-nod-hae-treatment-andembry-csl-set-compete-takedas-blockbuster-takhzyro</link>
<guid isPermaLink="false">33a7d939f753320070e7d398c30f4af8</guid>
<dc:creator>
<![CDATA[ Kevin Dunleavy ]]>
</dc:creator>
<pubDate>Tue, 17 Jun 2025 15:10:51 GMT</pubDate>
<media:content medium="image" url="https://qtxasset.com/quartz/qcloud5/media/image/ANDEMBRY3.jpg?VersionId=gWgco.U5tuhO301XyrDe2IVYCkzdy8Wh"/>
</item>
<item>
<title>
<![CDATA[ Shrinking budgets and rising targets pile pressure on pharma marketers: survey ]]>
</title>
<description>
<![CDATA[ <div><img src="https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1077553686.jpg?VersionId=_mZ3qxbJO1Ugb9X0vRNwmkH9eXutAtY." style="width: 100%;" /><div>European marketers are feeling the squeeze, with a combination of shrinking budgets, rising targets and tightening compliance requirements piling on the pressure,</div></div> ]]>
</description>
<link>https://www.fiercepharma.com/marketing/shrinking-budgets-and-rising-targets-pile-pressure-pharma-marketers-survey</link>
<guid isPermaLink="false">b40877aba3a96b03ce4d4cf4d228b909</guid>
<dc:creator>
<![CDATA[ Nick Paul Taylor ]]>
</dc:creator>
<pubDate>Tue, 17 Jun 2025 14:53:25 GMT</pubDate>
<media:content medium="image" url="https://qtxasset.com/quartz/qcloud5/media/image/GettyImages-1077553686.jpg?VersionId=_mZ3qxbJO1Ugb9X0vRNwmkH9eXutAtY."/>
</item>
<item>
<title>
<![CDATA[ Pharma roars onto the Cannes Pharma Lions podium, with Viatris winning Grand Prix and Biogen taking home Gold ]]>
</title>
<description>
<![CDATA[ <div><img src="https://qtxasset.com/quartz/qcloud5/media/image/canneslionstrophy.jpg?VersionId=GcioSKRGd.L8G1FX5NmKrb0QWbOVoCEW" style="width: 100%;" /><div>With Viatris taking home the biggest prize at this year’s Cannes Pharma Lions award and Biogen winning Gold, pharma is making a comeback. | This year's Pharma Lions awards at the Cannes Lions International Festival of Creativity saw the Grand Prix prize going to to Viatris and its "Make Love Last" Viagra campaign.</div></div> ]]>
</description>
<link>https://www.fiercepharma.com/marketing/pharma-represents-cannes-pharma-lions-podium-viatris-winning-grand-prix-and-biogen-taking</link>
<guid isPermaLink="false">be3f291afa9fde63cb34a770d052f94d</guid>
<dc:creator>
<![CDATA[ Zoey Becker ]]>
</dc:creator>
<pubDate>Tue, 17 Jun 2025 14:30:00 GMT</pubDate>
<media:content medium="image" url="https://qtxasset.com/quartz/qcloud5/media/image/canneslionstrophy.jpg?VersionId=GcioSKRGd.L8G1FX5NmKrb0QWbOVoCEW"/>
</item>
</channel>
</rss>
